Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-04-17 | Theresa M. Heggie was appointed to the Board in December 2018. ... The Company has an Audit Committee, currently consisting of Mr. Lee, as its Chairman, Mr. Abercrombie and Ms. Heggie. |
| 2020-03-31 | Theresa M. Heggie was appointed to the Board in December 2018. Ms. Heggie currently serves as Senior Vice President, Head of Europe, Middle East, Africa & Canada for Alnylam Pharmaceuticals, Inc., a global commercial-stage biopharmaceutical company. ... The Company has an Audit Committee, currently consisting of Mr. Lee, as its Chairman, Mr. Abercrombie, Ms. Heggie, and Mr. Levin, which is responsible for the review of internal accounting controls, financial reporting and related matters. ... 2019 DIRECTOR COMPENSATION ... The following table provides information related to the compensation of our non-employee directors during fiscal 2019. ... Theresa M. Heggie 60,625 59,088 – – 119,710 ... The Audit Committee currently consists of Mr. Lee, as Chairman, Mr. Abercrombie, Ms. Heggie, and Mr. Levin. |
| 2021-04-13 | Theresa M. Heggie was initially appointed to the Board in December 2018. ... The Company has a Compensation Committee, currently consisting of Dr. Hutson, Mr. Aselage, and Mr. Ingram. ... 2020 DIRECTOR COMPENSATION ... Theresa M. Heggie 207,185 |
| 2023-04-27 | Theresa M. Heggie was initially appointed to the Board in December 2018... The Company’s Audit Committee currently consists of Mr. Lee, as its Chair, Mr. Abercrombie, Ms. Heggie (since February 2023), Mr. Levin, and Mr. Milano... The Company’s Corporate Governance and Nominating Committee currently consists of Ms. Heggie, as its Chair (since February 2023), Mr. Abercrombie, Dr. Hutson, and Dr. McKee... 2022 Director Compensation: Theresa M. Heggie total compensation $417,348. |
Data sourced from SEC filings. Last updated: 2026-02-03